Hematologic Malignancy
Acute Lymphoblastic Leukemia
CI-CAN-00000400ALLExplore in graph →
Hematologic546 active trials12 approved drugs43 evidence items
- NCIt
- C3167
- DOID
- 9952
- MeSH
- D054198
- Other
- 3 more codes
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00000400ALLExplore in graph →
Clinical trials
2,037 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (268)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02730299 | Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS | completed | Phase 3 | 125 | Gamida Cell ltdINDUSTRY | 10 | Feb 25, 2026 | clinicaltrials |
| NCT05350787 | Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With R/R B-ALL | completed | Phase 1 | 10 | Zhejiang UniversityOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT06705530 |
| A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative Disorders |
| completed |
| Phase 1 / Phase 2 |
| 58 |
| National Research Center for Hematology, RussiaNETWORK |
| 1 |
| Feb 9, 2026 |
| clinicaltrials |
| NCT05694364 | Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies | completed | Phase 1 | 3 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT06578351 | TRacking Atopic Dermatitis Infants and Their Microbiome (TRAM)(TRAM) | completed | — | 60 | Danone Asia Pacific Holdings Pte, Ltd.INDUSTRY | 1 | Feb 4, 2026 | clinicaltrials |
| NCT05784415 | Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell(CS22-03) | completed | — | 30 | AIDS Malignancy ConsortiumNETWORK | 1 | Feb 2, 2026 | clinicaltrials |
| NCT04800510 | Iterative Design of Custom Dynamic Orthoses(PRMRP-Norms) | completed | N/A | 9 | University of IowaOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT04681105 | Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies | completed | Phase 1 | 13 | City of Hope Medical CenterOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT05622682 | Vaccine Immune Recovery After Leukemia(VIRAL) | completed | — | 89 | Children's Hospital of PhiladelphiaOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT04139434 | Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML | completed | Phase 1 | 32 | Newave Pharmaceutical IncINDUSTRY | 2 | Jan 23, 2026 | clinicaltrials |
| NCT02862652 | Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children.(THROMBLEUKEMIA) | completed | N/A | 24 | CHU de ReimsOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT05275543 | Robot Rehab: AAI With Robot During Inpatient Pediatric Rehab | completed | N/A | 25 | University of NebraskaOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT05466994 | A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study) | completed | Phase 2 | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT03414775 | Influences of High-fiber, Organic Whole-food Formula on the Gut Microbiome in Critically Ill Children | completed | N/A | 32 | University of PittsburghOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT03904134 | Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)(BMT CTN 1702) | completed | N/A | 1,753 | Center for International Blood and Marrow Transplant ResearchNETWORK | 1 | Jan 5, 2026 | clinicaltrials |
| NCT04913038 | Validation of the ANI in Perpubescent Patients in Pediatric Intensive Care Unit.(ANI-EP) | completed | — | 50 | University Hospital, LilleOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT02881086 | Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | completed | Phase 3 | 1,023 | Goethe UniversityOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT04191187 | Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies | completed | Phase 2 | 34 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 11, 2025 | clinicaltrials |
| NCT02328014 | Acalabrutinib (ACP-196) in Combination With ACP-319, for Treatment of B-Cell Malignancies | completed | Phase 1 / Phase 2 | 40 | Acerta Pharma BVINDUSTRY | 1 | Dec 9, 2025 | clinicaltrials |
| NCT05923112 | BESPONSA Injection 1 mg Special Investigation | completed | — | 421 | PfizerINDUSTRY | 1 | Dec 5, 2025 | clinicaltrials |
| NCT03898128 | ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate(INO-CD22) | completed | — | 84 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT05687032 | A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | completed | Phase 4 | 44 | PfizerINDUSTRY | 1 | Dec 3, 2025 | clinicaltrials |
| NCT01139970 | Veliparib and Temozolomide in Treating Patients With Acute Leukemia | completed | Phase 1 | 66 | National Cancer Institute (NCI)NIH | 1 | Nov 20, 2025 | clinicaltrials |
| NCT02996773 | Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine | completed | Phase 1 | 50 | University of ArizonaOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT03160079 | Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts | completed | Phase 1 / Phase 2 | 16 | University of California, San DiegoOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT06244147 | Long Term Safety and Efficacy of KSM-66 Ashwagandha in Adults | completed | — | 200 | SF Research Institute, Inc.NETWORK | 1 | Nov 6, 2025 | clinicaltrials |
| NCT02879643 | Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy | completed | Phase 1 | 29 | Therapeutic Advances in Childhood Leukemia ConsortiumOTHER | 3 | Oct 22, 2025 | clinicaltrials |
| NCT00136435 | A Study in Adults With Untreated Acute Lymphoblastic Leukemia | completed | Phase 2 | 100 | Dana-Farber Cancer InstituteOTHER | 2 | Oct 20, 2025 | clinicaltrials |
| NCT03480438 | Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab(EWALL-BOLD) | completed | Phase 2 | 52 | Goethe UniversityOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT04984356 | A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL | completed | Phase 1 | 28 | Allotera TherapeuticsINDUSTRY | 4 | Sep 30, 2025 | clinicaltrials |
| NCT06389357 | Retun-to-school Adaptation Program for Children With Cancer(web-based) | completed | N/A | 20 | Gazi UniversityOTHER | 1 | Sep 29, 2025 | clinicaltrials |
| NCT05506683 | Improving Nighttime Access to Care and Treatment; Part 2- Ghana(INACT2-G) | completed | N/A | 1,239 | University of FloridaOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT07162558 | The Effect of Child-centered Empowerment on Lifestyle of Leukemia Patients(lifestyle) | completed | N/A | 46 | Near East University, TurkeyOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT06655181 | Evaluating the Effectiveness of Respiratory Muscle Training in Pediatric Kidney Transplant Patient | completed | N/A | 30 | Atlas UniversityOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT00357565 | Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia | completed | Phase 2 | 34 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT06027957 | CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia | completed | Phase 1 | 18 | Vinmec Research Institute of Stem Cell and Gene TechnologyOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT07041216 | Squishy Toy and Palpation in Pediatric IV Success(Intravenous) | completed | N/A | 90 | Akdeniz UniversityOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT01660607 | Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell | completed | Phase 1 / Phase 2 | 68 | Stanford UniversityOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT03957915 | Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia(INA03) | completed | Early Phase 1 | 33 | Institut Paoli-CalmettesOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT05964322 | Cardiac Rehabilitation of Children and Adolescent With Long QT Syndrome(RYTHMO'FIT) | completed | — | 8 | University Hospital, MontpellierOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT04473911 | Haplo Peripheral Blood Sct In GVHD Prevention | completed | Phase 1 | 25 | Zachariah Michael DeFilippOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT05019144 | Telemedicine Optimized Burn Intervention(TOBI) | completed | N/A | 130 | Medical University of South CarolinaOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT04669210 | PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT(PTCyRuxo) | completed | Phase 2 | 128 | St. Petersburg State Pavlov Medical UniversityOTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT04400071 | Biology and Benefits of Music Play and Stories for Kids/Parents During ALL Treatment | completed | N/A | 192 | Indiana UniversityOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT07039383 | A Real-world Study of the Effectiveness of Tisagenlecleucel in Acute Lymphoblastic Leukemia Patients(KareALL) | completed | — | 79 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 26, 2025 | clinicaltrials |
| NCT02446964 | Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia | completed | Phase 1 | 31 | City of Hope Medical CenterOTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT00674479 | INCB018424 in Patients With Advanced Hematologic Malignancies | completed | Phase 2 | 51 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT00476190 | ALL Adult Consortium Trial: Adult ALL Trial | completed | Phase 2 | 112 | Dana-Farber Cancer InstituteOTHER | 2 | Jun 12, 2025 | clinicaltrials |
| NCT06709248 | Feasibility of a Life Coping Program: A Study Protocol(LifeCOPE) | completed | N/A | 54 | Haukeland University HospitalOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT03613363 | Engineering Evaluation of the Helix Ventilator | completed | N/A | 20 | Philips RespironicsINDUSTRY | 1 | Jun 6, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Feb 25, 2026source: clinicaltrials